Published in J Biol Chem on March 10, 1973
Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal. J Cell Biol (1975) 1.13
Transbilayer distribution and movement of cholesterol and phospholipid in the membrane of influenza virus. Proc Natl Acad Sci U S A (1976) 1.01
Interaction of phosphatidylserine-phosphatidylcholine liposomes with sickle erythrocytes. Evidence for altered membrane surface properties. J Clin Invest (1983) 0.86
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
Atherogenesis: a postprandial phenomenon. Circulation (1979) 3.74
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet (1982) 2.56
Role of phosphatidylinositol in attachment of alkaline phosphatase to membranes. Biochemistry (1980) 2.04
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Exchange of phospholipids between liver mitochondria and microsomes in vitro. J Biol Chem (1968) 1.72
Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci U S A (2000) 1.67
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66
Serum complement and familial combined hyperlipidemia. Atherosclerosis (1997) 1.64
Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases. J Am Geriatr Soc (1997) 1.59
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med (1982) 1.45
Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem (1993) 1.43
An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta (1975) 1.43
The composition and structure of lymph chylomicrons in dog, rat, and man. J Clin Invest (1965) 1.42
Participation of soluble liver proteins in the exchange of membrane phospholipids. Biochim Biophys Acta (1969) 1.42
Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits. J Lipid Res (1977) 1.40
The OSBP-related protein family in humans. J Lipid Res (2001) 1.40
Purification and characterization of lipoprotein lipase from pig adipose tissue. J Biol Chem (1974) 1.39
Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J Biol Chem (1983) 1.37
Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J Lipid Res (1982) 1.36
Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation (1995) 1.35
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis (1994) 1.32
Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res (1988) 1.31
The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem (2001) 1.30
The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis (2001) 1.29
Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. Atherosclerosis (1994) 1.25
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest (1987) 1.25
A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res (1973) 1.25
Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes (1977) 1.23
Stimulation of cholesterol ester exchange by lipoprotein-free rabbit plasma. Biochim Biophys Acta (1975) 1.22
Asymmetry and transposition rates of phosphatidylcholine in rat erythrocyte ghosts. Biochemistry (1976) 1.21
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet (1999) 1.21
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis (1996) 1.20
The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem J (1996) 1.19
Rat liver proteins capable of transferring phosphatidylethanolamine. Purification and transfer activity for other phospholipids and cholesterol. J Biol Chem (1977) 1.19
Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes. BMJ (1994) 1.18
The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes (2001) 1.17
Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells. J Cell Sci (1998) 1.16
Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits. J Lipid Res (1988) 1.16
Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med (1994) 1.15
Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. Biochim Biophys Acta (1971) 1.14
PCR amplification of alleles at the DIS80 locus: comparison of a Finnish and a North American Caucasian population sample, and forensic casework evaluation. Am J Hum Genet (1992) 1.13
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res (1989) 1.13
Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. Chem Phys Lipids (1985) 1.12
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res (2001) 1.11
Validation of a dual-isotope plasma ratio method for measurement of cholesterol absorption in rats. J Lipid Res (1974) 1.11
Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation (1979) 1.10
Two nonspecific phospholipid exchange proteins from beef liver. I. Purification and characterization. Biochemistry (1980) 1.10
Membrane insertion and intracellular transport of yeast syntaxin Sso2p in mammalian cells. J Cell Sci (1994) 1.10
A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. J Biol Chem (1981) 1.10
Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation (2000) 1.10
Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma. Biochemistry (1972) 1.09
Cholesteryl ester exchange protein in human plasma isolation and characterization. Biochim Biophys Acta (1978) 1.08
Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis (1990) 1.08
The surface coat of chylomicrons: lipid chemistry. J Lipid Res (1968) 1.07
Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med (1976) 1.07
Application of DNA "fingerprints" to paternity determinations. Lancet (1988) 1.07
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis (2000) 1.06
Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis (1986) 1.06
Preparation, characterization, and measurement of hepatic lipase. Methods Enzymol (1986) 1.06
Increased lipid transfer activities in hyperlipidemic rabbit plasma. Arteriosclerosis (1986) 1.06
The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest (1996) 1.06
A sec1-related vesicle-transport protein that is expressed predominantly in epithelial cells. Eur J Biochem (1996) 1.06
Heterogeneity of primary lipoprotein lipase deficiency. Metabolism (1980) 1.05
The OSBP-related proteins (ORPs): global sterol sensors for co-ordination of cellular lipid metabolism, membrane trafficking and signalling processes? Biochem Soc Trans (2006) 1.04
Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis (1995) 1.04
The role of phagocytosis in the development of atherosclerotic lesions in the rabbit. Atherosclerosis (1972) 1.04
Fate of intravenously administered particulate and lipoprotein cholesterol in the rat. J Lipid Res (1972) 1.03
Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci U S A (1984) 1.03
Release from alveolar macrophages of an inhibitor of phagocytosis. Am J Physiol (1970) 1.03
Use of phospholipid exchange protein to measure inside-outside transposition in phosphatidylcholine liposomes. Biochim Biophys Acta (1975) 1.02
Studies on the defect underlying the lysosomal storage of sialic acid in Salla disease. Lysosomal accumulation of sialic acid formed from N-acetyl-mannosamine or derived from low density lipoprotein in cultured mutant fibroblasts. J Clin Invest (1986) 1.01
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Diabetologia (2010) 1.01
Changes in serum lipids, lipoproteins, and heparin releasable lipolytic enzymes during moderate physical training in man: a longitudinal study. Metabolism (1981) 1.01
Complete exchangeability of cholesterol in phosphatidylcholine/cholesterol vesicles of different degrees of unsaturation. Biochemistry (1977) 1.01
Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J (1994) 1.00
Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum Mol Genet (2001) 1.00
Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles. J Biol Chem (1979) 0.99
The surface coat of chylomicrons: electron microscopy. J Lipid Res (1968) 0.99
Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Molecular size as a determinant of plasma lipoprotein influx. Arteriosclerosis (1981) 0.98
Metabolism of chylomicrons by the isolated rat liver. J Lipid Res (1967) 0.98
Purification and characterization of lipoprotein lipase from pig myocardium. Biochem J (1975) 0.98
High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology (1994) 0.97
Extensive exchange of rat liver microsomal phospholipids. Biochim Biophys Acta (1977) 0.97
Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta (1996) 0.97
Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res (1990) 0.97
Purification from human plasma of a heparin-released lipase with activity against triglyceride and phospholipids. J Biol Chem (1975) 0.97
Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J Lipid Res (2000) 0.96
Net transfer of phospholipid by the nonspecific phospholipid transfer proteins from bovine liver. Biochim Biophys Acta (1980) 0.96
Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. J Lipid Res (1998) 0.96
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis (1989) 0.96
A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression. J Lipid Res (1996) 0.96
Lipoprotein lipase activity in bovine aorta. Proc Soc Exp Biol Med (1975) 0.95
Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem J (1995) 0.95